Saturday, July 19, 2025

If Rep. Thomas Massie can get this new legislation passed, Covid-19 VACCINE MAKERS will be liable for injuries and deaths caused by DEADLY CLOT SHOTS

 Introduction to the PREP Repeal Act

- Rep. Thomas Massie introduced H. R. 4388, the PREP Repeal Act

- Aims to revoke the Public Readiness and Emergency Preparedness (PREP) Act of 2005

- The PREP Act provides legal immunity to vaccine manufacturers and promoters during health emergencies

Key Points of the Bill

- Seeks to remove liability protections for COVID-19 vaccine makers

- Could allow thousands of lawsuits for injuries or deaths from pandemic-related products

- Challenges the constitutionality of the PREP Act, claiming it violates the 10th Amendment

Restoration of Legal Rights

- Massie argues the PREP Act undermines constitutional rights and due process

- Calls current protections "medical malpractice martial law"

- The bill would also end the Countermeasures Injury Compensation Program (CICP)

Criticism of Current Compensation System

- CICP has a high denial rate (over 98%) for COVID-19 injury claims

- Critics argue that it fails to compensate injured individuals adequately

- The bill may shift claims to the National Vaccine Injury Compensation Program (VICP), which has stricter eligibility

Potential Impact of the Bill

- If passed, it could expose vaccine makers and pharmacy chains to legal liability

- Would affect protections linked to other public health emergencies

Legislative Challenges

- The bill faces significant opposition and may not pass without strong public support

- Legal experts warn it could create chaos in the healthcare system

- Previous similar legislation, the LIABLE Act, did not gain traction

Public Support Importance

- Massie and supporters highlight the need for widespread public backing

- Legislative change could offer more lasting protections for victims than executive orders 

https://www.naturalnews.com/2025-07-18-rep-massie-new-legislation-covid19-vaccine-makers-liable.html

No comments: